AI주식인사이트AI Stock Insight
B

퓨쳐켐

220100KOSDAQ

58.7 / 100

Reference Date: 2026-09-09

Financial Score15.5 / 40
News Sentiment20.2 / 25
Momentum8.0 / 20
Disclosure15.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 7.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

FutureChem develops radiopharmaceuticals by researching peptides similar to proteins specifically expressed in certain diseases, offering diagnostic and therapeutic drugs. Key products include FC303 for prostate cancer diagnosis and FC705 for treatment, leveraging theranostics technology for personalized medicine. The company utilizes the sCUBE® automated synthesis system to achieve GMP-level manufacturing standards.

Number of Employees

94people

Average Salary

53.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
3.31Industry Average 1.200.0Point

2.8x industry avg (risky)

ROE
-20.50Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
9.30Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲15.9% (2-year basis)

Operating Profit Growth Rate
1.0 / 3

Avg ▲2.8% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -15.5% (declining, 3yr)

Detailed News Sentiment

8 totalPositive 7Neutral 1Negative 0Average Sentiment Score 80.6

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 8,100Won52-week high 34,20052-week low 6,910
1-month return1.0Point

1m -7.64% (falling)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

20 totalPositive 3Neutral 17Negative 0
  • Positive[기재정정]유상증자또는주식관련사채등의청약결과(자율공시)2026-09-07
  • Positive유상증자또는주식관련사채등의청약결과(자율공시)2026-09-04
  • Positive유상증자최종발행가액확정2026-09-01
  • Neutral[발행조건확정]증권신고서(지분증권)2026-09-01
  • Neutral[기재정정]투자설명서2026-09-01